Cancer Patients With Diabetes May Have Worse Outcomes on ICIs
Cancer patients with type 2 diabetes may have worse survival outcomes on immune checkpoint inhibitor therapy, a new study suggests.
Diagnosis & Disease Information
Nivolumab sBLA Accepted for Patients With Completely Resected Stage IIB, IIC Melanoma
The sBLA is supported by data from the phase 3 CheckMate -76K trial which included 790 patients after complete resection of stage IIB or IIC melanoma.
Male Firefighters May Have Higher Risk for Melanoma
Occupational case-control studies addressing melanoma risk in career firefighters are reviewed.
ACS Report Shows Prostate Cancer on the Rise, Cervical Cancer on the Decline
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
Accredited Hospitals Fail to Disclose Costs of Common Cancer Surgeries
Roughly half of hospitals accredited by the ACS-CoC failed to disclose the cost of 5 common cancer surgeries, researchers found.
Low-Dose Methotrexate May Increase Risk of Melanoma
Exposure to low-dose methotrexate is associated with an increased risk of melanoma, according to a meta-analysis of 17 studies.
No Survival Benefit With T-VEC in Advanced Melanoma
Adding T-VEC to pembrolizumab does not improve survival in patients with advanced melanoma, a phase 3 study suggests.
Data Reveal Growing Burden of Metastatic Cancers in the US
The prevalence of metastatic cancers in the US has risen in recent years and will increase further by 2025, according to researchers.
Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Incidence of Melanoma Diagnosis, Biopsy Parallel Skin Screening Uptake
Researchers sought to determine if the incidence of melanoma diagnoses and biopsies increased with a greater uptake of skin screenings.
- Loading...
Loading...
Loading... 
Loading...